Roivant Sciences Ltd (ROIV)

Roivant Sciences Ltd Borsa (ROIV) Ultime notizie

Critical Insights From Roivant Sciences Analyst Ratings: What You Need To Know

Benzinga

Where Roivant Sciences Stands With Analysts

Benzinga

The Analyst Landscape: 4 Takes On Roivant Sciences

Benzinga

Roivant to Report Financial Results for the Third Quarter Ended December 31, 2023, and Provide Business Update on Tuesday, February 13, 2024

GlobeNewswire Inc.

Analyst Highlights Aclaris Therapeutics' Encouraging Efficacy For Eczema Candidate, But Cautions On Data Variations

Benzinga

Assessing Roivant Sciences: Insights From 5 Financial Analysts

Benzinga

Roivant Reports Positive Initial Phase 2 Results for Batoclimab in Graves’ Disease

GlobeNewswire Inc.

FedEx Posts Downbeat Earnings, Joins Steelcase, argenx And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session

Benzinga

Analyst Ratings for Roivant Sciences

Benzinga

8 Analysts Have This to Say About Roivant Sciences

Benzinga

Stock Market News for Nov 14, 2023

Zacks Investment Research